Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Depreciation & Amortization (CF) (2016 - 2025)

Immucell (ICCC) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $708667.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization (CF) rose 3.32% year-over-year to $708667.0, compared with a TTM value of $2.8 million through Sep 2025, up 1.06%, and an annual FY2024 reading of $2.7 million, changed 0.36% over the prior year.
  • Depreciation & Amortization (CF) was $708667.0 for Q3 2025 at Immucell, up from $679037.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $709098.0 in Q3 2023 and bottomed at $603161.0 in Q4 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $658324.5, with a median of $677500.0 recorded in 2024.
  • The sharpest move saw Depreciation & Amortization (CF) increased 13.0% in 2023, then dropped 3.27% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $603161.0 in 2021, then grew by 0.5% to $606174.0 in 2022, then grew by 13.0% to $684979.0 in 2023, then dropped by 0.05% to $684655.0 in 2024, then rose by 3.51% to $708667.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for ICCC at $708667.0 in Q3 2025, $679037.0 in Q2 2025, and $686773.0 in Q1 2025.